Clinical aspects of hyperlipidaemia.
Disagreement about the epidemiological aspects of hyperlipidaemia has meant that many onlookers have become disenchanted with its clinical importance. This is unfortunate because new insights into the metabolism of the hyperlipidaemias have established clearer indications for treatment.
D000328:Adult; D002648:Child; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D003327:Coronary Disease / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000378:metabolism*; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000378:metabolism / Q000628:therapy; D006952:Hyperlipoproteinemia Type III / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D014973:Xanthomatosis / Q000209:etiology
D002914:Chylomicrons; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D002792:Cholestyramine Resin